2000
DOI: 10.1067/mai.2000.110922
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
100
0
1

Year Published

2001
2001
2019
2019

Publication Types

Select...
3
3
2

Relationship

1
7

Authors

Journals

citations
Cited by 122 publications
(109 citation statements)
references
References 25 publications
5
100
0
1
Order By: Relevance
“…The cytokine profile associated with a particular reaction determines the nature of the induced immune response (1, 38-42). Ag (43,44), was not seen in piperacillin-hypersensitive patients, and this may relate to the absence of eosinophilia as a clinical feature. The detection of IL-1b, TNF-a, and IL-6 in culture supernatant containing piperacillin-stimulated PBMCs from hypersensitive patients and tolerant controls (albeit to a lesser extent) are suggestive of a dendritic cell response against piperacillin, as has recently been described with amoxicillin (45,46).…”
Section: Discussionmentioning
confidence: 99%
“…The cytokine profile associated with a particular reaction determines the nature of the induced immune response (1, 38-42). Ag (43,44), was not seen in piperacillin-hypersensitive patients, and this may relate to the absence of eosinophilia as a clinical feature. The detection of IL-1b, TNF-a, and IL-6 in culture supernatant containing piperacillin-stimulated PBMCs from hypersensitive patients and tolerant controls (albeit to a lesser extent) are suggestive of a dendritic cell response against piperacillin, as has recently been described with amoxicillin (45,46).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, they indicate that even in some neutrophil-rich inflammatory responses specific T cells are engaged and might orchestrate the immune reaction. T cells from the circulation (19,20) and an enhanced eotaxin production by endothelial cells and infiltrating T cells (19). Interestingly, previous studies in patients with AGEP have revealed a high rate of strongly positive patch tests to drugs compared with patients with other drug eruptions (21)(22)(23)(24).…”
mentioning
confidence: 99%
“…In addition, immunohistochemistry was performed of skin biopsy specimens from the acute lesions as well as from the positive epicutaneous test reactions at 48 hours (patients AP and JS). The biopsy specimens were snapfrozen in tissue-embedding medium using isopentane precooled in liquid nitrogen and stored at -80°C.Immunostaining for IL-5 and RANTES was performed using the alkaline phosphatase anti-alkaline phosphatase (APAAP) method (D0651; Diagnostics AG, Zug, Switzerland) and for CD4, CD8, CD25, human leukocyte antigen-DR (HLA-DR), neutrophil elastase, EG2, eotaxin, and IL-8 using the avidin-biotin complex/alkaline phosphatase method (K0376; Diagnostics AG), as described previously in detail (8,19). Finally, all sections were developed in fuchsin substrate-chromogen (K0624; Diagnostics AG) and counterstained with hematoxylin (Haemalaun; Dr. Grogg Chemie AG, Stettlen, Switzerland).…”
mentioning
confidence: 99%
“…In MPE or DRESS an increase has also been found in IL-5 and chemokines such as RANTES and eotaxins, which explains the involvement of eosinophils expressing CCR3 (Hertl et al, 1993). In AGEP, another severe delayed drug-induced reaction, lymphocytes have a dual role as cytotoxic agents and inducing migration of neutrophils to the skin by producing IL-8 (Britschgi & Pichler, 2002;Hertl et al, 1993;Padial et al, 2004;Yawalkar et al, 2000). At the acute phase of TEN, T cells are recruited to the skin, producing cytotoxic markers such as perforin and granzyme B (Fernandez et al, 2010;Mayorga et al, 2003;Pichler, 2003;Posadas et al, 2002;Torres et al, 2006;Zawodniak et al, 2010), and they express high levels of CCR10 and their chemokine CCL27 .…”
Section: Monitoring Delayed Reaction To Drugsmentioning
confidence: 99%
“…Different studies have shown the good sensitivity and specificity of the LTT, with heterogeneity in the drugs and clinical entities (Luque et al, 2001;Naisbitt et al, 2003aNaisbitt et al, , 2003bNyfeler & Pichler, 1997;. The most frequent drugs studied are beta-lactam antibiotics and anti-epileptics, particularly carbamazepine (Hertl et al, 1993;Luque et al, 2001;Mauri-Hellweg et al, 1995;Nyfeler & Pichler, 1997;Tapia et al, 2004;Yawalkar et al, 2000). These studies have shown an overall sensitivity of 60-70% for LTT (Lerch et al, 2007;Luque et al, 2001;Mauri-Hellweg et al, 1995;Pichler & Tilch, 2004).…”
Section: Lymphocyte Transformation Testmentioning
confidence: 99%